Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy

Toxicity and Activity of a Twice Daily High-dose Bolus Interleukin 2 Regimen in Patients With Metastatic Melanoma and Metastatic Renal Cell Cancer

(2009) Nicolas Acquavella et al.   JOURNAL OF IMMUNOTHERAPY

In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)

(2008) Malarvizhi Durai et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response

(2008) Xiaoling Lu et al.   CANCER LETTERS

The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells

(2008) R. Zappasodi et al.   HAEMATOLOGICA

Adoptive T-cell therapy for malignant disorders

(2008) D. J. Powell et al.   HAEMATOLOGICA

Cancer Immunotherapy by Dendritic Cells

(2008) Cornelis J.M. Melief   IMMUNITY

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

(2008) Mark E. Dudley et al.   JOURNAL OF CLINICAL ONCOLOGY

A Comprehensive Platform for Ex Vivo T-cell Expansion Based on Biodegradable Polymeric Artificial Antigen-presenting Cells

(2008) Erin R Steenblock et al.   MOLECULAR THERAPY

Cancer Immunology

(2008) Olivera J. Finn   NEW ENGLAND JOURNAL OF MEDICINE

Engineering Biodegradable Polyester Particles With Specific Drug Targeting and Drug Release Properties

(2007) Farahidah Mohamed et al.   JOURNAL OF PHARMACEUTICAL SCIENCES